{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:26:19Z","timestamp":1788870379151,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":410,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Policy Research Programme in the Department of Health, UK","award":["039\/030"],"award-info":[{"award-number":["039\/030"]}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","award":["EPI-HPV-109903"],"award-info":[{"award-number":["EPI-HPV-109903"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000355","name":"The BUPA Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000355","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.04.006","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T11:19:18Z","timestamp":1334575158000},"page":"3867-3875","source":"Crossref","is-referenced-by-count":43,"title":["Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation"],"prefix":"10.1016","volume":"30","author":[{"given":"Rebecca","family":"Howell-Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Akpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippa","family":"Oakeshott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Carder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Sillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Mallinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vic","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frodsham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Ian","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Noel","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Beddows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Soldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2012.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"9686","key":"10.1016\/j.vaccine.2012.04.006_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.006_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","article-title":"Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England","volume":"103","author":"Howell-Jones","year":"2010","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC Trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.006_bib0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6603955","article-title":"Prevalence of human papillomavirus antibodies in young female subjects in England","volume":"97","author":"Jit","year":"2007","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0035","unstructured":"Health Protection Agency. STI Annual Data Tables. Table 4: number of selected STI diagnoses made at genitourinary medicine clinics by gender, sexual orientation and age-group, UK, England and English SHAs: 2000\u20132009; 2010 http:\/\/www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1203348026613#1._STI_Report [last accessed 14.02.11]."},{"issue":"24","key":"10.1016\/j.vaccine.2012.04.006_bib0040","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1016\/j.vaccine.2009.09.125","article-title":"Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom","volume":"28","author":"Choi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0045","doi-asserted-by":"crossref","first-page":"a769","DOI":"10.1136\/bmj.a769","article-title":"Economic evaluation of human papillomavirus vaccination in the United Kingdom","volume":"337","author":"Jit","year":"2008","journal-title":"British Medical Journal"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0050","series-title":"Report of the meeting on HPV vaccine coverage and impact monitoring 16\u201317 November 2009","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0055","doi-asserted-by":"crossref","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":"Randomised controlled trial of screening for Chlamdydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial","volume":"340","author":"Oakeshott","year":"2010","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.006_bib0060","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of Hybrid Capture 2","volume":"46","author":"Castle","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.006_bib0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JCM.02022-06","article-title":"Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems","volume":"45","author":"Payan","year":"2007","journal-title":"Journal of Clinical Microbiology"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.006_bib0070","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1128\/JCM.01305-06","article-title":"Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology","volume":"44","author":"Castle","year":"2006","journal-title":"Journal of Clinical Microbiology"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.006_bib0075","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1055-9965.EPI-07-2904","article-title":"A comparison of Linear Array and Hybrid Capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study","volume":"17","author":"Gravitt","year":"2008","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.006_bib0080","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JCM.02438-06","article-title":"Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results","volume":"45","author":"Stevens","year":"2007","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0090","unstructured":"National Centre for Social Research, et al. National survey of sexual attitudes and lifestyles II, 2000\u20132001 [computer file]. Colchester, Essex: UK Data Archive [distributor], August 2005. SN: 5223."},{"key":"10.1016\/j.vaccine.2012.04.006_bib0095","series-title":"Population estimates by ethnic group (experimental): current estimates\u2014population estimates by ethnic group mid-2007 (experimental)","author":"Office for National Statistics","year":"2010"},{"issue":"23","key":"10.1016\/j.vaccine.2012.04.006_bib0100","first-page":"2","article-title":"Major step forward in chlamydia screening in 2009\/10","volume":"4","author":"Health Protection Agency","year":"2010","journal-title":"Health Protection Report"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/sti.2010.047027","article-title":"Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data","author":"Riha","year":"2011","journal-title":"Sexually Transmitted Infections"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0110","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(01)06886-6","article-title":"Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection","volume":"358","author":"Fenton","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0115","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(01)06885-4","article-title":"Sexual behaviour in Britain: early heterosexual experience","volume":"358","author":"Wellings","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.006_bib0120","first-page":"513","article-title":"Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grad squamous intraepithelial lesions","volume":"163","author":"Sellors","year":"2000","journal-title":"Canadian Medical Association Journal"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.006_bib0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/OLQ.0b013e318064c8c5","article-title":"A comparison of cervical and vaginal human papillomavirus","volume":"34","author":"Castle","year":"2007","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0130","doi-asserted-by":"crossref","unstructured":"National Chlamydia Screening Programme. The bigger picture the national chlamydia screening programme 2008\/09 annual report; November 2009.","DOI":"10.12968\/indn.2009.30.1.76387"},{"issue":"9271","key":"10.1016\/j.vaccine.2012.04.006_bib0135","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.04.006_bib0140","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection","volume":"181","author":"Carter","year":"2000","journal-title":"The Journal of Infectious Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.006_bib0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 virus like particle vaccine among young women with pre-existing infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"The Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.006_bib0150","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1055-9965.EPI-08-1186","article-title":"Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies","volume":"18","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T06:45:37Z","timestamp":1561617937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12005257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":30,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12005257"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}